Cargando…

Study of diffusion‐weighted magnetic resonance imaging in the evaluation of the response to AAV2‐VEGF‐Trap neoadjuvant treatment in a triple‐negative breast cancer animal model

OBJECTIVE: Evaluation of the efficacy of adeno‐associated virus 2 mediated gene transfer of vascular endothelial growth factor Trap (AAV2‐VEGF‐Trap) alone or combination with paclitaxel in a mouse model of triple‐negative breast cancer (TNBC) using diffusion‐weighted magnetic resonance imaging (DW‐M...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jianhua, Zhu, Pengjin, Wang, Lei, Yang, Li, Zou, Liqun, Gao, Fabao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488150/
https://www.ncbi.nlm.nih.gov/pubmed/30900382
http://dx.doi.org/10.1002/cam4.1963
_version_ 1783414610744836096
author Li, Jianhua
Zhu, Pengjin
Wang, Lei
Yang, Li
Zou, Liqun
Gao, Fabao
author_facet Li, Jianhua
Zhu, Pengjin
Wang, Lei
Yang, Li
Zou, Liqun
Gao, Fabao
author_sort Li, Jianhua
collection PubMed
description OBJECTIVE: Evaluation of the efficacy of adeno‐associated virus 2 mediated gene transfer of vascular endothelial growth factor Trap (AAV2‐VEGF‐Trap) alone or combination with paclitaxel in a mouse model of triple‐negative breast cancer (TNBC) using diffusion‐weighted magnetic resonance imaging (DW‐MRI) and in vivo fluorescence imaging. MATERIALS AND METHODS: Xenografted TNBC tumors were established by subcutaneous injection of MDA‐MB‐231 cells into nude mice. Tumors were treated with AAV2‐VEGF‐Trap, paclitaxel, AAV2‐VEGF‐Trap combined with paclitaxel and control. A 7.0‐Tesla magnetic resonance (MR) was used to obtain the apparent diffusion coefficient (ADC) values and ΔADC values. In vivo fluorescence imaging coupled with the optical imaging probe AngioSense680 EX was acquired to obtain average luminous intensity values. Immunohistochemical staining of tumor Ki‐67 and vascular endothelial cell marker antigen (CD31) were used to evaluate the effects on tumor proliferation and angiogenesis. RESULTS: The combination of AAV2‐VEGF‐Trap with paclitaxel exhibited greater tumor growth inhibition compared with the other groups. The ADC values in the paclitaxel group and the AAV2‐VEGF‐Trap in combination with paclitaxel group were significant greater compared with the control group, and the ΔADC values of all treatment groups were significantly increased compared with the control group on the 14th day after administration. Decreased microvessel density and luminous intensity in the treatment groups that contain AAV2‐VEGF‐Trap were observed. Reduced proliferation activity was noted in groups that contained paclitaxel. CONCLUSION: AAV2‐VEGF‐Trap inhibits TNBC growth though inhibiting tumor neovascularization with a single intravenous injection, and AAV2‐VEGF‐Trap exhibits a synergistic effect when used in combination with paclitaxel for TNBC neoadjuvant therapy. In vivo fluorescence imaging can detect the anti‐angiogenesis effect of AAV2‐VEGF‐Trap early and noninvasively. DW‐MRI can longitudinally monitor the neoadjuvant efficacy of TNBC.
format Online
Article
Text
id pubmed-6488150
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64881502019-05-23 Study of diffusion‐weighted magnetic resonance imaging in the evaluation of the response to AAV2‐VEGF‐Trap neoadjuvant treatment in a triple‐negative breast cancer animal model Li, Jianhua Zhu, Pengjin Wang, Lei Yang, Li Zou, Liqun Gao, Fabao Cancer Med Clinical Cancer Research OBJECTIVE: Evaluation of the efficacy of adeno‐associated virus 2 mediated gene transfer of vascular endothelial growth factor Trap (AAV2‐VEGF‐Trap) alone or combination with paclitaxel in a mouse model of triple‐negative breast cancer (TNBC) using diffusion‐weighted magnetic resonance imaging (DW‐MRI) and in vivo fluorescence imaging. MATERIALS AND METHODS: Xenografted TNBC tumors were established by subcutaneous injection of MDA‐MB‐231 cells into nude mice. Tumors were treated with AAV2‐VEGF‐Trap, paclitaxel, AAV2‐VEGF‐Trap combined with paclitaxel and control. A 7.0‐Tesla magnetic resonance (MR) was used to obtain the apparent diffusion coefficient (ADC) values and ΔADC values. In vivo fluorescence imaging coupled with the optical imaging probe AngioSense680 EX was acquired to obtain average luminous intensity values. Immunohistochemical staining of tumor Ki‐67 and vascular endothelial cell marker antigen (CD31) were used to evaluate the effects on tumor proliferation and angiogenesis. RESULTS: The combination of AAV2‐VEGF‐Trap with paclitaxel exhibited greater tumor growth inhibition compared with the other groups. The ADC values in the paclitaxel group and the AAV2‐VEGF‐Trap in combination with paclitaxel group were significant greater compared with the control group, and the ΔADC values of all treatment groups were significantly increased compared with the control group on the 14th day after administration. Decreased microvessel density and luminous intensity in the treatment groups that contain AAV2‐VEGF‐Trap were observed. Reduced proliferation activity was noted in groups that contained paclitaxel. CONCLUSION: AAV2‐VEGF‐Trap inhibits TNBC growth though inhibiting tumor neovascularization with a single intravenous injection, and AAV2‐VEGF‐Trap exhibits a synergistic effect when used in combination with paclitaxel for TNBC neoadjuvant therapy. In vivo fluorescence imaging can detect the anti‐angiogenesis effect of AAV2‐VEGF‐Trap early and noninvasively. DW‐MRI can longitudinally monitor the neoadjuvant efficacy of TNBC. John Wiley and Sons Inc. 2019-03-21 /pmc/articles/PMC6488150/ /pubmed/30900382 http://dx.doi.org/10.1002/cam4.1963 Text en © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cancer Research
Li, Jianhua
Zhu, Pengjin
Wang, Lei
Yang, Li
Zou, Liqun
Gao, Fabao
Study of diffusion‐weighted magnetic resonance imaging in the evaluation of the response to AAV2‐VEGF‐Trap neoadjuvant treatment in a triple‐negative breast cancer animal model
title Study of diffusion‐weighted magnetic resonance imaging in the evaluation of the response to AAV2‐VEGF‐Trap neoadjuvant treatment in a triple‐negative breast cancer animal model
title_full Study of diffusion‐weighted magnetic resonance imaging in the evaluation of the response to AAV2‐VEGF‐Trap neoadjuvant treatment in a triple‐negative breast cancer animal model
title_fullStr Study of diffusion‐weighted magnetic resonance imaging in the evaluation of the response to AAV2‐VEGF‐Trap neoadjuvant treatment in a triple‐negative breast cancer animal model
title_full_unstemmed Study of diffusion‐weighted magnetic resonance imaging in the evaluation of the response to AAV2‐VEGF‐Trap neoadjuvant treatment in a triple‐negative breast cancer animal model
title_short Study of diffusion‐weighted magnetic resonance imaging in the evaluation of the response to AAV2‐VEGF‐Trap neoadjuvant treatment in a triple‐negative breast cancer animal model
title_sort study of diffusion‐weighted magnetic resonance imaging in the evaluation of the response to aav2‐vegf‐trap neoadjuvant treatment in a triple‐negative breast cancer animal model
topic Clinical Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488150/
https://www.ncbi.nlm.nih.gov/pubmed/30900382
http://dx.doi.org/10.1002/cam4.1963
work_keys_str_mv AT lijianhua studyofdiffusionweightedmagneticresonanceimagingintheevaluationoftheresponsetoaav2vegftrapneoadjuvanttreatmentinatriplenegativebreastcanceranimalmodel
AT zhupengjin studyofdiffusionweightedmagneticresonanceimagingintheevaluationoftheresponsetoaav2vegftrapneoadjuvanttreatmentinatriplenegativebreastcanceranimalmodel
AT wanglei studyofdiffusionweightedmagneticresonanceimagingintheevaluationoftheresponsetoaav2vegftrapneoadjuvanttreatmentinatriplenegativebreastcanceranimalmodel
AT yangli studyofdiffusionweightedmagneticresonanceimagingintheevaluationoftheresponsetoaav2vegftrapneoadjuvanttreatmentinatriplenegativebreastcanceranimalmodel
AT zouliqun studyofdiffusionweightedmagneticresonanceimagingintheevaluationoftheresponsetoaav2vegftrapneoadjuvanttreatmentinatriplenegativebreastcanceranimalmodel
AT gaofabao studyofdiffusionweightedmagneticresonanceimagingintheevaluationoftheresponsetoaav2vegftrapneoadjuvanttreatmentinatriplenegativebreastcanceranimalmodel